Erisyon Inc. is commercializing the world’s first single-molecule protein sequencer that promises to transform the way we detect, treat, and track disease.

Erisyon Inc. is commercializing the world’s first single-molecule protein sequencer that promises to transform the way we detect, treat, and track disease.